Searching for Tourette's syndrome gene. Part 2. Patient's genome variability;W poszukiwaniu genu zespołu Tourette'a. Czȩść 2. Zmienność genomu chorych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 89-95

  Kowalska, Anna ^a   Midro, Alina T ^b   Janik, Piotr ^c   Gogol, Anna ^c   Słuzewski, Wojciech ^c   Rajewski, Andrzej ^c  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chromosomal rearrangements; CNVs (copy number variations); SNP (single nucleotide polymorphisms)

Indexed keywords

HISTAMINE;

CHROMOSOME MAP; COPY NUMBER VARIATION; GENE REARRANGEMENT; GENETICS; GENOME; GILLES DE LA TOURETTE SYNDROME; HUMAN; METABOLISM; MUTATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPTIC TRANSMISSION;

CHROMOSOME MAPPING; DNA COPY NUMBER VARIATIONS; GENE REARRANGEMENT; GENOME; HISTAMINE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNAPTIC TRANSMISSION; TOURETTE SYNDROME;

EID: 84867938035     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Abelson J. F., Kwan K. Y., O'Roak B. J., Baek D. Y., Stillman A. A., Morgan T. M., Mathews C. A., Pauls D. L., Rasin M. R., Gunel M., Davis N. R., Ercan-Sencicek A. G., Guez D. H., Spertus J. A., Leckman J. F., Dure L. S. IV, Kurlan R., Singer H. S., Gilbert D. L., Farhi A., Louvi A., Lifton R. P., Sestan N., State M. W.: Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science, 2005;310:317-320
2. Aruga J., Mikoshiba K.: Identification and characterization of Slitrk, a novel neuronal transmembrane protein family cotrolling neurite outgrowth. Mol. Cell. Neurosci., 2003;24:117-129
3. Belloso J. M., Bache I., Guitart M., Caballin M. R., Halgren C., Kirchhoff M., Ropers H. H., Tommerup N., Tümer Z.: Disruption of the CNTNAP2 gene in a t (7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur. J. Hum. Genet., 2007;15:711-713
4. Boghosian-Sell L., Comings D. E., Overhauser J.: Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. Am. J. Hum. Genet., 1996;59:999-1005
5. Breedveld G. J., Fabbrini G., Oostra B. A., Berardelli A., Bonifati V.: Tourette disorder spectrum maps to chromosome 14q31.1 in an Italian kindred. Neurogenetics, 2010;11:417-423
6. Brett P. M., Curtis D., Robertson M. M., Dahlitz M., Gurling H. M.: Linkage analysis and exclusion of regions of chromosomes 3 and 8 in Gilles de la Tourette syndrome following the identification of a balanced reciprocal translocation 46 XY, t (3:8) (p21.3 q24.1) in a case of Tourette syndrome. Psychiatr. Genet., 1996;6:99-105
7. Chou I. C., Lin H. C., Wang C. H., Lin W. D., Lee C. C., Tsai C. H., Tsai F. J.: Polymorphisms of interleukin 1 gene IL1RN are associated with Tourette syndrome. Pediatr. Neurol., 2010;42:320-324
8. Chou I. C., Tsai C. H., Lee C. C., Kuo H. T., Hsu Y. A., Li C. I., Tsai F. J.: Association analysis between Tourette's syndrome and dopamine D1 receptor gene in Taiwanese children. Psychiatr. Genet., 2004;14:219-221
9. Chou I. C., Wan L., Liu S. C., Tsai C. H., Tsai F. J.: Association of the Slit and Trk-line 1 gene in Taiwanese patients with Tourette syndrome. Pediatr. Neurol., 2007;37:404-406
10. Comings D. E., Comings B. G., Devor E. J., Cloninger C. R.: Detection of major gene for Gilles de la Tourette syndrome. Am. J. Hum. Genet., 1984;36:586-600
11. Comings D. E., Gade R., Muhleman D., Chiu C., Wu S., To M., Spence M., Dietz G., Winn-Deen E., Rosenthal R. J., Lesieur H. R., Rugle L., Sverd J., Ferry L., Johnson J. P., MacMurray J. P.: Exon and intron variants in the human tryptophan 2, 3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Pharmacogenetics, 1996;6:307-318
12. Comings D. E., Muhleman D., Dietz G., Dino M., Le Gro R., Gade R.: Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet, 1993;341:906
13. Comings D. E., Wu S., Chiu C., Ring R. H., Gade R., Ahn C., MacMurray J. P., Dietz G., Muhleman D.: Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes. Am. J. Med. Genet., 1996;67:264-288
14. Cowperthwaite M., Mohanty D., Burnett M. G.: Genome-wide association studies: a powerful tool for neurogenomics. Neurosurg. Focus, 2010;28:E2
15. Crawford F. C., Ait-Ghezala G., Morris M., Sutcliffe M. J., Hauser R. A., Silver A. A., Mullan M. J.: Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum. Genet., 2003;113:154-161
16. Cruz C., Camarena B., King N., Páez F., Sidenberg D., de la Fuente J. R., Nicolini H.: Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorders with tics. Neurosci. Lett., 1997;231:1-4
17. Cuker A., State M. W., King RA., Davis N., Ward D. C.: Candidate locus for Gilles de la Tourette syndrome/obsessive compulsive disorder/chronic tic disorder at 18q22. Am. J. Med. Genet. A., 2004;130 A: 37-39
18. de Carvalho Aguiar P, Fazzari M., Jankovic J., Ozelius L. J.: Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder. Mov. Disord., 2004;19:1237-1238
19. Dehning S., Riedel M., Muller N.: Father-to son transmission of 6;17 translocation in Tourette's syndrome. Am. J. Psychiatry, 2008;165:1051-1052
20. Deng H., Le W. D., Xie W. J., Jankovic J.: Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol. Scand., 2006;114:400-402
21. Devor E. J.: The D2 dopamine receptor and tourette's syndrome. JAMA, 1992;267:651
22. Diaz-Anzaldua A., Joober R., Riviere J. B., Dion Y., Lespérance P., Richer F., Chouinard S., Rouleau G. A., Montreal Tourette Syndrome Study Group: Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. Mol. Psychiatry, 2004;9:272-277
23. Dickel D. E., Veenstra-Vander Weele J., Bivens N. C., Wu X., Fischer D. J., Van Etten-Lee M., Himle J. A., Leventhal B. L., Cook E. H. Jr, Hanna G. L.: Association studies of serotonin system candidate genes in early-onset obessive-compulsive disorder. Biol. Psychiatry, 2007;61:322-329
24. Donnai D.: Gene location in Tourette syndrome. Lancet, 1987;329:627
25. Elia J., Gai X., Xie H. M., Perin J. C., Geiger E., Glessner J. T., D'arcy M., de Berardinis R., Frackelton E., Kim C., Lantieri F., Muganga B. M., Wang L., Takeda T., Rappaport E. F., Grant S. F., Berrettini W., Devoto M., Shaikh T. H., Hakonarson H., White P. S.: Rare structural variants found in attention-deficit hiperactivity disorder are preferentially associated with neurodevelopmental genes. Mol. Psychiatry, 2010;15:637-646
26. Ercan-Sencicek A. G., Stillman A. A., Ghosh A. K., Bilguvar K., O'Roak B. J., Mason C. E., Abbott T., Gupta A., King R. A., Pauls D. L., Tischfield J. A., Heiman G. A., Singer H. S., Gilbert D. L., Hoekstra P. J., Morgan T. M., Loring E., Yasuno K., Fernandez T., Sanders S., Louvi A., Cho J. H., Mane S., Colangelo C. M., Biederer T., Lifton R. P., Gunel M., State M. W.: L-histidine decarboxylase and Tourette syndrome. N. Engl. J. Med., 2010;362:1901-1908
27. Fabbrini G., Pasquini M., Aurilia C., Berardelli I., Breedveld G., Oostra B. A., Bonifati V., Berardelli A.: A large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene. Mov. Disord., 2007;22:2229-2234
28. Gade R., Muhleman D., Blake H., Johnson P., Verde R., Saucier G., Comings D. E.: Correlation of lenght of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry, 1998;3:50-60
29. Gadzicki D., Müller-Vahl K. R., Heller D., Ossege S., Nöthen M. M., Hebebrand J., Stuhrmann M.: Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2004;127 B: 97-103
30. Glessner J. T., Wang K., Cai G., Korvatska O., Kim C. E., Wood S., Zhang H., Estes A., Brune C. W., Bradfield J. P., Imielinski M., Frackelton E. C., Reichert J., Crawford E. L., Munson J., Sleiman P. M., Chiavacci R., Annaiah K., Thomas K., Hou C., Glaberson W., Flory J., Otieno F., Garris M., Soorya L., Klei L., Piven J., Meyer K. J., Anagnostou E., Sakurai T., Game R. M., Rudd D. S., Zurawiecki D., McDougle C. J., Davis L. K., Miller J., Posey D. J., Michaels S., Kolevzon A., Silverman J. M., Bernier R., Levy S. E., Schultz R. T., Dawson G., Owley T., McMahon W. M., Wassink T. H., Sweeney JA., Nurnberger J. I., Coon H., Sutcliffe J. S., Minshew N. J., Grant S. F., Bucan M., Cook E. H., Buxbaum J. D., Devlin B., Schellenberg G. D., Hakonarson H.: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 2009, 259:569-573
31. Haas H. L., Sergeeva O. A., Selbach O.: Histamine in the nervous system. Physiol. Rev., 2008;88:1183-1241
32. Hebebrand J., Nothen M. M., Lehmkuhl G., Poustka F., Schmidt M., Propping P., Remschmidt H.: Tourette's syndrome and homozygosity for the dopamine D3 receptor gene. Lancet, 1993;341:1483-1484
33. Huang Y., Li T., Wang Y., Ansar J., Lanting G., Liu X., Zhao J. H., Hu X., Sham P. C., Collier D.: Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligodendrocyte glycoprotein in Tourette's syndrome patients from a Chinese sample. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2004;124 B: 76-80
34. Huang Y., Liu X., Li T., Guo L., Sun X., Xiao X., Ma X., Wang Y., Collier D. A.: Cases-control association study and transmission disequilibrium tesr of T102C polymorphism in 5HT2A and Tourette syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2001;18:11-13
35. Kroisel P. M., Petek E., Emberger W., Windpassinger C., Wladika W., Wagner K.: Candidate region for Gilles de la Tourette syndrome at 7q31. Am. J. Med. Genet., 2001;101:259-261
36. Lee C. C., Chou I. C., Tsai C. H., Wang T. R., Li T. C., Tsai F. J.: Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatr. Neurol., 2005;33:272-276
37. Matsumoto N., David D. E., Johnson E., Konecki D., Burmester J. K., Ledbetter D. H., Weber J. L.: Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome. Eur. J. Hum. Genet., 2000;8:875-883
38. Merikangas A. K., Corvin A. P., Gallagher L.: Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet., 2009;25:536-544
39. Miranda D. M., Wigg K., Kabia E. M., Feng Y., Sandor P., Barr C. L.: Association of SLITRK1 to Gilles de la Tourette syndrome. Am. J. Med. Genet. Neuropsychiatr. Genet., 2009;150 B: 483-486
40. Niesler B., Frank B., Hebebrand J., Rappold G.: Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatr. Genet., 2005;15:303-304
41. Noble E. P.: The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics, 2000;1:309-333
42. Patel C., Cooper-Charles L., McMullan D. J., Walker J. M., Davison V., Morton J.: Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome. Eur. J. Hum. Genet., 2011;19:634-639
43. Petek E., Schwarzbraun, Noor A., Patel M., Nakabayashi K., Choufani S., Windpassinger C., Stamenkovic M., Robertson M. M., Aschauer H. N., Gurling H. M., Kroisel P. M., Wagner K., Scherer S. W., Vincent J. B.: Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome. Mol. Genet. Genomics, 2007;277:71-81
44. Petek E., Windpassinger C., Vincent J. B., Cheung J., Boright A. P., Scherer S. W., Kroisel P. M., Wagner K.: Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am. J. Hum. Genet., 2001;68:848-858
45. Poot M., Beyer V., Schwaab I., Damatova N., Van't Slot R., Prothero J., Holder S. E., Haaf T.: Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder. Neurogenetics, 2010;11:81-89
46. Robertson M. M., Shelley B. P., Dalwai S., Brewer C., Critchley H. D.: A patient with both Gilles de la Tourette's syndrome and chromosome 22q11 deletion syndrome: clue to the genetics of Gilles de la Tourette's syndrome? J. Psychosom. Res., 2006;61:365-368
47. Rowe D. C., Stever C., Gard J. M., Cleveland H. H., Sanders M. L., Abramowitz A., Kozol S. T., Mohr J. H., Sherman S. L., Waldman I. D.: The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav. Genet., 1998;28:215-225
48. Schoenian S., Konig I., Oertel W., Remschmidt H., Ziegler A., Hebebrand J., Bandmann O.: HLA-DRB genotyping in Gilles de la Tourette patients and their parents. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2003;119 B: 60-64
49. Shelley B. P., Robertson M. M., Turk J.: An individual with GTS and Smith-Magenis microdeletion syndrome: is chromosome 17q11.2 a candidate region for TS putative susceptibility genes? J. Intelect. Disabil. Res., 2007;51:620-624
50. State M. W., Greally J. M., Cuker A., Bowers P. N., Henegariu O., Morgan T. M., Gunel M., Di Luna M., King R. A., Nelson C., Donovan A., Anderson G. M., Leckman J. F., Hawkins T., Pauls D. L., Lifton R. P., Ward D. C.: Epigenetic abnormalities associated with a chromosome 18 (q21-q22) inversion and a Gilles de la Tourette syndrome phenotype. Proc. Natl. Acad. Sci. USA, 2003;100:4684-4689
51. Stillman A. A., Krsnik Z., Sun J., Rasin M. R., State M. W., Sestan N., Louvi A.: Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J. Comp. Neurol., 2009;513:21-37
52. Sundaram S. K., Huq A. M., Wilson B. J., Chugani H. T.: Tourette syndrome is associated with recurrent exonic copy number variants. Neurology, 2010, 74:1583-1590
53. Tarnok Z., Ronai Z., Gervai J., Kereszturi E., Gadoros J., Sasvari-Szekely M., Nemoda Z.: Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3'UTR polymorphism of dopamine transporter gene. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2007;144 B: 900-905
54. Taylor L. D., Krizman D. B., Jankovic J., Hayani A., Steuber P. C., Greenberg F., Fenwick R. G., Caskey C. T.: 9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology, 1991;41:1513-1515
55. Verkerk A. J., Mathews C. A., Joosse M., Eussen B. H., Heutink P., Oostra B. A., Tourette Syndrome Association International Consortium for Genetics: CNTNAP2 is disrupted in family with Gilles de la Tourette syndrome and obessive compulsive disorder. Genomics, 2003, 82:1-9
56. Yoon D. Y., Rippel C. A., Kobets A. J., Morris C. M., Lee J. E., Williams P. N., Bridges D. D., Vandenbergh D. J., Shugart Y. Y., Singer H. S.: Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2007;144 B: 605-610
57. Zimprich A., Hatala K., Riederer F., Stogmann E., Aschauer H. N., Stamenkovic M.: Sequence analysis of the complete SLITRK1 gene in Austrian patients with Tourette's disorder. Psychiatr. Genet., 2008;18:308-309